Trial intelligence / Profile preview

RESET Trial of S-ketamine for pain in chronic pancreatitis

2013-003357-17Phase 4Terminated

Sponsor
Prof. Asbjørn Mohr Drewes
Start
Nov 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of esketamine in chronic pancreatitis (CP) (2 arms), sponsored by Prof. Asbjørn Mohr Drewes. Primary endpoints: Pain relief in daily pain diary and Experimental analgesic and anti-hyperalgesic effects. Started Nov 2013; status: terminated.

02

Drugs

esketamine
03

Conditions

chronic pancreatitis (CP)

Beyond the preview

Go deeper on 2013-003357-17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-003357-17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call